Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/simcere-and-connect-enter-into-an-exclusive-license-and-collaboration-agreement-for-the-innovative-autoimmune-drug-rademikibart-301996539.html
https://www.fiercebiotech.com/biotech/simcere-links-connect-pays-21m-cash-rights-eczema-asset-china
https://www.prnewswire.com/news-releases/four-innovative-drugs-launched-in-three-years-hkex--listed-simcere-pharmaceutical-group-is-on-the-fast-track-toward-building-an-innovation-driven-global-pharmaceutical-company-301805331.html
https://www.prnewswire.com/news-releases/simcere-zaiming-announces-clinical-collaboration-to-evaluate-sim0235-a-tnfr2-monoclonal-antibody-in-combination-with-keytruda-pembrolizumab-in-a-phase-1-trial-in-advanced-solid-tumors-and-cutaneous-t-cell-lymphoma-301771277.html
https://www.prnewswire.com/news-releases/first-prescription-for-cosela-trilaciclib-issued-in-china-301743018.html
https://www.reuters.com/world/china/china-approves-two-domestically-developed-covid-drugs-2023-01-29/
https://www.prnewswire.com/news-releases/ascletis-announces-entering-into-a-supply-agreement-of-ritonavir-tablets-with-simcere-301722875.html
https://www.prnewswire.com/news-releases/phase-iiiii-clinical-trial-of-simceres-3cl-targeting-anti-sars-cov-2-drug-candidate-complete-all-patients-enrollment-301707093.html
https://endpts.com/for-30m-chinese-biopharma-simcere-picks-up-regional-rights-to-idorsias-insomnia-drug/